DK165406C - Substituerede n-(2,4,6-trimethoxyphenyl)-fedtsyreamider, fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende disse forbindelser samt anvendelse af disse forbindelser til fremstilling af et farmaceutisk praeparat til inhibering af intestinal absorption af kolesterol - Google Patents

Substituerede n-(2,4,6-trimethoxyphenyl)-fedtsyreamider, fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende disse forbindelser samt anvendelse af disse forbindelser til fremstilling af et farmaceutisk praeparat til inhibering af intestinal absorption af kolesterol

Info

Publication number
DK165406C
DK165406C DK094188A DK94188A DK165406C DK 165406 C DK165406 C DK 165406C DK 094188 A DK094188 A DK 094188A DK 94188 A DK94188 A DK 94188A DK 165406 C DK165406 C DK 165406C
Authority
DK
Denmark
Prior art keywords
compounds
trimethoxyphenyl
procedures
substituted
preparing
Prior art date
Application number
DK094188A
Other languages
Danish (da)
English (en)
Other versions
DK165406B (da
DK94188D0 (da
DK94188A (da
Inventor
Milton Louis Hoefle
Ann Holmes
Bruce David Roth
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK94188D0 publication Critical patent/DK94188D0/da
Publication of DK94188A publication Critical patent/DK94188A/da
Publication of DK165406B publication Critical patent/DK165406B/da
Application granted granted Critical
Publication of DK165406C publication Critical patent/DK165406C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK094188A 1987-02-24 1988-02-23 Substituerede n-(2,4,6-trimethoxyphenyl)-fedtsyreamider, fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende disse forbindelser samt anvendelse af disse forbindelser til fremstilling af et farmaceutisk praeparat til inhibering af intestinal absorption af kolesterol DK165406C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/017,960 US4716175A (en) 1987-02-24 1987-02-24 Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
US1796087 1987-02-24

Publications (4)

Publication Number Publication Date
DK94188D0 DK94188D0 (da) 1988-02-23
DK94188A DK94188A (da) 1988-08-25
DK165406B DK165406B (da) 1992-11-23
DK165406C true DK165406C (da) 1993-04-13

Family

ID=21785503

Family Applications (1)

Application Number Title Priority Date Filing Date
DK094188A DK165406C (da) 1987-02-24 1988-02-23 Substituerede n-(2,4,6-trimethoxyphenyl)-fedtsyreamider, fremgangsmaade til fremstilling deraf, farmaceutisk praeparat indeholdende disse forbindelser samt anvendelse af disse forbindelser til fremstilling af et farmaceutisk praeparat til inhibering af intestinal absorption af kolesterol

Country Status (17)

Country Link
US (1) US4716175A (de)
EP (1) EP0283742B1 (de)
JP (1) JPH07121895B2 (de)
KR (1) KR880009933A (de)
AT (1) ATE89814T1 (de)
CA (1) CA1336913C (de)
DE (1) DE3881249T2 (de)
DK (1) DK165406C (de)
ES (1) ES2056843T3 (de)
FI (1) FI89593C (de)
HK (1) HK148195A (de)
IE (1) IE59998B1 (de)
MX (1) MX9203139A (de)
NO (1) NO174043C (de)
NZ (1) NZ223410A (de)
PT (1) PT86811B (de)
ZA (1) ZA88604B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827152D0 (en) * 1988-11-21 1988-12-29 Wellcome Found Anti-atherosclerotic diaryl compounds
US5290814A (en) * 1988-11-21 1994-03-01 Burroughs Wellcome Co. Anti-atherosclerotic diaryl compounds
US5153226A (en) * 1989-08-31 1992-10-06 Warner-Lambert Company Acat inhibitors for treating hypocholesterolemia
WO1991004027A1 (en) * 1989-09-15 1991-04-04 Pfizer Inc. New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
AU6659090A (en) * 1989-11-16 1991-06-13 Warner-Lambert Company Acat inhibitors
AU7745991A (en) * 1990-04-11 1991-10-30 Warner-Lambert Company Amide ester acat inhibitors
US5149709A (en) * 1990-07-03 1992-09-22 Schering Corporation Inhibitors of acyl-coenzyme A: cholesterol acyl transferase
CA2087423A1 (en) * 1990-07-25 1992-01-26 Tatsuki Shiota Benzopyran derivative, process for producing the same and pharmaceutical composition containing the same
US5668136A (en) * 1990-09-25 1997-09-16 Eisai Co., Ltd. Trisubstituted benzene derivatives, composition and methods of treatment
WO1992009572A1 (en) * 1990-11-26 1992-06-11 Taisho Pharmaceutical Co., Ltd. Anilide derivative
FR2673625B1 (fr) * 1991-03-08 1993-05-07 Adir Nouveaux derives d'acylaminophenol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5420164A (en) * 1991-04-04 1995-05-30 Yoshitomi Pharmaceutical Industries, Ltd. Cycloalkylurea compounds
JP3087307B2 (ja) * 1991-12-25 2000-09-11 大正製薬株式会社 アニリド誘導体
RU94046149A (ru) * 1992-05-28 1996-11-27 Пфайзер Инк. (US) Новые n-арил и n-гетероарил производные мочевины как ингибиторы ацил кофермента а:холестерин ацил трансферазы (асат) фармацевтическая композиция, способ ингибирования (асат)
WO1994002452A1 (fr) * 1992-07-20 1994-02-03 Eisai Co., Ltd. Derive du benzene
US5321031A (en) * 1992-09-23 1994-06-14 Schering Corporation 1,2-disubstituted ethyl amides as inhibitors of ACAT
CA2107196A1 (en) * 1992-09-29 1994-03-30 Mitsubishi Chemical Corporation Carboxamide derivatives
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
US5534529A (en) * 1993-06-30 1996-07-09 Sankyo Company, Limited Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5596001A (en) * 1993-10-25 1997-01-21 Pfizer Inc. 4-aryl-3-(heteroarylureido)quinoline derivatves
IT1265209B1 (it) * 1993-11-22 1996-10-31 Pierrel Spa Difenilimidazoli utili nel trattamento di dislipidemia, arteriosclerosi e malattie coronariche procedimento per la loro
US6133326A (en) 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
KR960031425A (ko) * 1995-02-08 1996-09-17 시미주 마사미 다중불포화된 지방산 잔기를 갖는 아닐린 유도체 및 그의 용도
HUP0301010A3 (en) * 2000-02-02 2005-03-29 Warner Lambert Co Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders and pharmaceutical compositions containing them
AU4368001A (en) * 2000-03-16 2001-09-24 Neurogen Corporation 5-substituted arylpyrimidines
US20040072903A1 (en) * 2001-05-08 2004-04-15 Auerbach Bruce Jeffrey Carboxyalkylether-acat inhibitors combinations
EP1281399A3 (de) * 2001-08-01 2004-02-11 Warner-Lambert Company Hemmer mit doppelter Wirkung auf Wachsester- und Cholesterylestersynthese zur Hemmung der Sebumproduktion
PT1725234E (pt) 2004-03-05 2013-03-04 Univ Pennsylvania Métodos com efeitos secundários reduzidos para tratamento de patologias ou doenças associadas a hiperlipidemia e hipercolesterolemia
US20100210633A1 (en) * 2006-10-12 2010-08-19 Epix Delaware, Inc. Carboxamide compounds and their use
AU2008335135A1 (en) 2007-12-11 2009-06-18 Cytopathfinder, Inc. Carboxamide compounds and their use as chemokine receptor agonists
EP2341924A4 (de) 2008-10-02 2013-01-23 David Gladstone Inst Verfahren zur behandlung von hepatitis-c-virusinfektionen
BR112023000808A2 (pt) 2020-07-29 2023-02-07 Amryt Pharmaceuticals Inc Lomitapida para uso em métodos para tratar hiperlipidemia e hipercolesterolemia em pacientes pediátricos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL238088A (de) * 1958-04-14
BE620639A (de) * 1961-07-25
SE353319B (de) * 1964-08-15 1973-01-29 Sumitomo Chemical Co
DE1618959C3 (de) * 1967-10-04 1978-12-14 Sumitomo Chemical Co., Ltd., Osaka (Japan) Fettsäureamide und Verfahren zu ihrer Herstellung
DE2830351A1 (de) * 1978-07-11 1980-01-24 Consortium Elektrochem Ind Acylanilide
GR69291B (de) * 1979-06-25 1982-05-13 May & Baker Ltd
US4410697A (en) * 1980-01-25 1983-10-18 Reanal Finomvegyszergyar Process for the preparation of N-aryl-N'-(mono- or di substituted)-urea derivatives
US4749812A (en) * 1985-05-27 1988-06-07 Mitsui Toatsu Chemicals, Inc. N-(3-chloro-4-isopropylphenyl) carboxamide derivative and selective herbicide
MA20552A1 (fr) * 1985-10-11 1986-07-01 Pan Medica Sa Alkylacarboxamides de pyridylalkylamines,leurs preparations et leurs utilisations

Also Published As

Publication number Publication date
US4716175B1 (de) 1993-06-22
DK165406B (da) 1992-11-23
KR880009933A (ko) 1988-10-05
EP0283742A2 (de) 1988-09-28
DE3881249D1 (en) 1993-07-01
PT86811B (pt) 1992-05-29
NO880774D0 (no) 1988-02-23
FI89593C (fi) 1993-10-25
IE880204L (en) 1988-08-24
US4716175A (en) 1987-12-29
MX9203139A (es) 1992-07-01
ES2056843T3 (es) 1994-10-16
ATE89814T1 (de) 1993-06-15
NO174043C (no) 1994-03-09
FI880796A0 (fi) 1988-02-19
ZA88604B (en) 1989-09-27
IE59998B1 (en) 1994-05-18
AU610558B2 (en) 1991-05-23
JPS63253060A (ja) 1988-10-20
NO880774L (no) 1988-08-25
AU1135488A (en) 1988-08-25
EP0283742A3 (en) 1989-07-26
DE3881249T2 (de) 1993-09-16
FI880796A7 (fi) 1988-08-25
FI89593B (fi) 1993-07-15
CA1336913C (en) 1995-09-05
PT86811A (pt) 1988-03-01
HK148195A (en) 1995-09-22
EP0283742B1 (de) 1993-05-26
NO174043B (no) 1993-11-29
NZ223410A (en) 1989-11-28
DK94188D0 (da) 1988-02-23
DK94188A (da) 1988-08-25
JPH07121895B2 (ja) 1995-12-25

Similar Documents

Publication Publication Date Title
US4716175B1 (de)
MX9203150A (es) Nuevos esteres de acidos tienilcarboxilicos de aminoalcoholes, sus productos de cuaternizacion y las composiciones farmaceuticas que los contienen.
FI884592L (fi) Entsyymien nesteformulaatio
FI862882A0 (fi) 1-substituerade oxindol-3 -karboxiamider som antiinflammatoriska och vaerkstillande medel.
FI880452L (fi) Menetelmä N-heterosyklisten N-(4-piperidyyli)-amidien valmistamiseksi
OA08241A (fr) Procédé de préparation du chlorhydrate de phényl-1 diéthylamino carbonyl-1 aminométhyl-2 cyclopropane (Z).
GR3001523T3 (en) Substituted pyrimidine amides of oleic or linoleic acid as inhibitors of acyl-coa cholesterol acyltransferase
DK314887D0 (da) Kompleksforbindelser, farmaceutiske midler med indhold heraf samt fremgangsmaade til fremstilling heraf
DK427288D0 (da) Thiomethyl- og sulfinylmethylderivater med mavesyresekretorisk aktivitet, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
DK152764C (da) Fremgangsmaade til fremstilling af et immobiliseret enzymprodukt
FI880151L (fi) -glutamyylitranspeptidaasin käyttö glutaryyli-7-amino- tai -ketoadipinyylikefalosporaanihapon entsymaattiseen hydrolysointiin
DK307085D0 (da) 4-phenyl-2-trifluormethyl-1,3-dioxan-5-ylheptensyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
FR2580667B1 (fr) Procede de preparation enzymatique de l-amino acides renfermant du soufre
PT88436A (pt) Process for the preparation of modified plasminogen activators
NO178325C (no) Fremgangsmåte for fremstilling av et t-PA injeksjonspreparat
DK194388D0 (da) Guanidincarboxylsyreestere, fremgangsmaade til fremstilling heraf samt laegemidler indeholdende disse forbindelser
PT87868A (pt) Processo para a preparacao de polopeptideos contendo homociclostatina e ciclostatinauteis como agentes anti-hipertensivos
IT8419056A1 (it) Procedimento per l'isolamento di L-amminoacidi
DZ1230A1 (fr) Procédé de préparation des cis-n-(3-méthoxy-4-pipéridinyl benzamides.
DK156775C (da) Fremgangsmaade til fremstilling af et immobiliseret enzymprodukt
DD269074A3 (de) Vorrichtung zur befestigung des kopfes von pruefmaschinen
LT2320B (lt) Fermentinis daviklis laktozes nustatymui
BR6500655U (pt) Apresentacao de produtos diversos
DK83488A (da) Phosphonsyre-derivater samt fremgangsmaade til fremstilling og anvendelse af saadanne derivater som mellemprodukter

Legal Events

Date Code Title Description
PBP Patent lapsed